MARGOLIS, S. Destined for Failure? An Analysis of the Biologics Price Competition and Innovation Act of 2009. Columbia Business Law Review, [S. l.], v. 2013, n. 1, p. 209–241, 2013. DOI: 10.7916/cblr.v2013i1.1794. Disponível em: https://journals.library.columbia.edu/index.php/CBLR/article/view/1794. Acesso em: 4 dec. 2024.